Last updated on June 2017

Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures


Brief description of study

This is a multicenter, open label study to assess the safety and pharmacokinetics of YKP3089 as adjunctive therapy in subjects with partial onset seizures. Initially, subjects taking phenytoin or phenobarbital will be enrolled followed by additional subjects taking anti-epileptic drugs other than phenytoin and phenobarbital to further investigate long-term safety.

Clinical Study Identifier: NCT02535091

Contact Investigators or Research Sites near you

Start Over

Yongwon Cho

Keimyung University Dongsan Hospital
Daegu, Korea, Republic of
  Connect »